Astrana Health Files 8-K for Regulatory Disclosure

Ticker: ASTH · Form: 8-K · Filed: May 15, 2024 · CIK: 1083446

Astrana Health, INC. 8-K Filing Summary
FieldDetail
CompanyAstrana Health, INC. (ASTH)
Form Type8-K
Filed DateMay 15, 2024
Risk Levellow
Pages2
Reading Time3 min
Sentimentneutral

Sentiment: neutral

Topics: regulatory-disclosure, financial-statements

TL;DR

Astrana Health filed a routine 8-K. No major news.

AI Summary

Astrana Health, Inc. filed an 8-K on May 14, 2024, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or material events beyond the standard reporting requirements.

Why It Matters

This 8-K filing serves as a standard disclosure for Astrana Health, Inc., informing the public of regulatory compliance and the submission of financial documents.

Risk Assessment

Risk Level: low — The filing is a standard 8-K report and does not indicate any unusual or high-risk events for the company.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for Astrana Health, Inc.?

The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to provide Financial Statements and Exhibits.

On what date was the earliest event reported in this filing?

The earliest event reported in this filing was on May 14, 2024.

What is the principal executive office address for Astrana Health, Inc.?

The principal executive office address is 1668 S. Garfield Avenue, 2nd Floor, Alhambra, California 91801.

What is the IRS Employer Identification Number for Astrana Health, Inc.?

The IRS Employer Identification Number for Astrana Health, Inc. is 95-4472349.

What were Astrana Health, Inc.'s former company names?

Astrana Health, Inc.'s former company names were Apollo Medical Holdings, Inc. and SICLONE INDUSTRIES INC.

Filing Stats: 736 words · 3 min read · ~2 pages · Grade level 12.6 · Accepted 2024-05-15 06:02:48

Filing Documents

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. Attached as Exhibit 99.1 to this Current Report on Form 8-K is a series of slides reflecting financial information about Astrana Health, Inc. (the "Company") for use by the Company in connection with potential meetings with investors and/or analysts. The Company does not undertake to update the information contained in the attached presentation materials. The information contained in this Current Report on Form 8-K, including the exhibit referenced herein, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section. Such information shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing. The furnishing of this information will not be deemed an admission as to the materiality of any information contained herein.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Investor Presentation (May 2024). 104 Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document).

Forward-Looking Statements

Forward-Looking Statements This Current Report on Form 8-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act. These statements include words such as "forecast," "guidance," "projects," "estimates," "anticipates," "believes," "expects," "intends," "may," "plans," "seeks," "should," or "will," or the negative of these words or similar words. Forward-looking statements involve certain risks and uncertainties, and actual results may differ materially from those discussed in each such statement. A number of important factors could cause actual results to differ materially from those included within or contemplated by the forward-looking statements, including, but not limited to, the factors described in the Company's filings with the Securities and Exchange Commission, including the Company's Annual Report on Form 10-K for the year ended December 31, 2023 and subsequent quarterly reports on Form 10-Q. The Company does not undertake any responsibility to update any of these factors or to announce publicly any revisions to any of the forward-looking statements contained in this or any other document, whether as a result of new information, future events, or otherwise.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ASTRANA HEALTH, INC. Date: May 14, 2024 By: /s/ Brandon Sim Name: Brandon Sim Title: Chief Executive Officer and President

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing